These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3309705)

  • 41. Platelet aggregation and recruitment with aspirin-clopidogrel therapy.
    Helgason CM; Grossi E; Pandey D; Valika A; Cursio J; Brace LD
    Cerebrovasc Dis; 2008; 25(5):392-400. PubMed ID: 18349532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Antithrombotic treatment in acute ischemia stroke].
    Díez-Tejedor E; Alonso de Leciñana M; Counsell C; Sandercock P
    Neurologia; 1995 Dec; 10 Suppl 2():48-54. PubMed ID: 8714450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EEG changes and platelet aggregation in experimental cerebral focal ischemia in rabbits.
    Bo P; Cosi V; Taccola A; Romani A; Savoldi F
    Boll Soc Ital Biol Sper; 1991 Jan; 67(1):71-5. PubMed ID: 1888474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of serum proteins on erythrocyte and thrombocyte aggregation].
    Mikheian EE; Akopov SE; Tunian IuS
    Patol Fiziol Eksp Ter; 1982; (1):23-5. PubMed ID: 7070851
    [No Abstract]   [Full Text] [Related]  

  • 45. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
    Croveri G
    Minerva Cardioangiol; 1980 Oct; 28(10):723-6. PubMed ID: 7465066
    [No Abstract]   [Full Text] [Related]  

  • 46. FK419, a novel nonpeptide GPIIb/IIIa antagonist, restores microvascular patency and improves outcome in the guinea-pig middle cerebral artery thrombotic occlusion model: comparison with tirofiban.
    Moriguchi A; Maeda M; Mihara K; Aoki T; Matsuoka N; Mutoh S
    J Cereb Blood Flow Metab; 2005 Jan; 25(1):75-86. PubMed ID: 15678114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Anti-platelet aggregation therapy and ischaemic cerebral accidents due to atheroma (author's transl)].
    Autret A
    Nouv Presse Med; 1982 May; 11(20):1543-7. PubMed ID: 7099931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurologic and visual symptoms in essential thrombocythemia: efficacy of low-dose aspirin.
    Koudstaal PJ; Koudstaal A
    Semin Thromb Hemost; 1997; 23(4):365-70. PubMed ID: 9263353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aspirin responsiveness in acute brain ischaemia: association with stroke severity and clinical outcome.
    Schwammenthal Y; Tsabari R; Shenkman B; Schwartz R; Matetzky S; Lubetsky A; Orion D; Israeli-Korn S; Chapman J; Savion N; Varon D; Tanne D
    Cerebrovasc Dis; 2008; 25(4):355-61. PubMed ID: 18305387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-molecular-weight heparin for the treatment of acute ischemic stroke.
    Bloom JM
    N Engl J Med; 1996 May; 334(21):1407. PubMed ID: 8614440
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of a micellar preparation of polyunsaturated phosphatidylcholine on platelet aggregation in vitro].
    Vlasova II; Torkhovskaia TI; Fortinskaia ES; Khalilov EM; Azizova OA
    Biull Eksp Biol Med; 1996 Feb; 121(2):199-203. PubMed ID: 9026131
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical and biochemical aspirin resistance in patients with recurrent cerebral ischemia.
    El-Mitwalli A; Azzam H; Abu-Hegazy M; Gomaa M; Wasel Y
    Clin Neurol Neurosurg; 2013 Jul; 115(7):944-7. PubMed ID: 23069275
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cilostazol in patients with ischemic stroke.
    Al-Qudah ZA; Hassan AE; Qureshi AI
    Expert Opin Pharmacother; 2011 Jun; 12(8):1305–1315. PubMed ID: 21548722
    [No Abstract]   [Full Text] [Related]  

  • 54. [Medico-surgical treatments in ischemic cerebrovascular diseases].
    Fields WS
    Neurologia; 1988; 3(5):187-92. PubMed ID: 3078766
    [No Abstract]   [Full Text] [Related]  

  • 55. Optical platelet aggregometry does not appear useful as a means of assessing the risk of recurrent vascular events in aspirin-treated patients.
    Sztriha LK; Sas K; Seres E; Boda K; Lenti L; Csifcsak G; Kovacs N; Vecsei L
    Acta Neurol Scand; 2008 Apr; 117(4):250-4. PubMed ID: 17961197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural insights in platelet receptor synergism-antiplatelet therapy in post-ischemic cerebrovascular events.
    Lahiri P; Chaudhuri U; Chattopadhyay A; Chakraborty P; Mandal D; Dasgupta AK
    Blood Cells Mol Dis; 2005; 34(3):248-56. PubMed ID: 15885609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serial change in platelet activation markers with aspirin and clopidogrel after acute ischemic stroke.
    Tsai NW; Chang WN; Shaw CF; Jan CR; Chang HW; Huang CR; Chen SD; Chuang YC; Lee LH; Lu CH
    Clin Neuropharmacol; 2010; 33(1):40-5. PubMed ID: 19855266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of ischaemic stroke: statins and antiplatelet agents.
    Cimminiello C; Romano A
    Neurol Sci; 2005 May; 26 Suppl 1():S24-5. PubMed ID: 15883685
    [No Abstract]   [Full Text] [Related]  

  • 59. [Antagonists of platelet P2 receptors: achievements, problems, and prospects].
    Ziganshin AY
    Eksp Klin Farmakol; 2010 Apr; 73(4):38-43. PubMed ID: 20486559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Platelet activity and the fibrinolytic system of blood in cerebral ischemia].
    Jovicić A; Malesević M
    Med Pregl; 1982; 35(5-6):185-9. PubMed ID: 7177059
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.